‘Star’ring In Conflict: Rogue IPTV Players Meet Star India In IP Battle

[This post is authored by Tanishka Goswami. Tanishka is an advocate at the High Court of MP. She graduated from National Law University, Delhi in 2023 & enjoys reading and writing on copyright laws. Her previous posts can be accessed here.] Though a recipient of widespread international popularity for its cost-effectiveness in accessing varied entertainment, news and sports content, the use of IPTV technology has always been clouded by legal challenges. One of these challenges pertain to piracy and illegal […]

‘Star’ring In Conflict: Rogue IPTV Players Meet Star India In IP Battle Read More »

Chalo Delhi! Office of CGPDTM Moves to New Delhi

CGPDTM has a new address- New Delhi. Ten days ago, the plan to shift the office from Mumbai to New Delhi, and the consequent social media spat between the Commerce Minister and Aditya Thackeray were in the news. After clarification by the Commerce Minister on his social media account and a round of political banter, discussed here, the Ministry of Commerce has published a short notification announcing that the headquarters of the CGPDTM along with the Establishment and Finance Division has been

Chalo Delhi! Office of CGPDTM Moves to New Delhi Read More »

Delhi High Court Stirs the Pot for Biotech Patent Applicants in India 

On the recent Delhi High Court judgement concerning a genetically modified salmonella bacteria, Prashant Reddy T writes on how the Court missed the boat in laying down the law on some important issues for the biotech industry concerning the patentability of microorganisms and disclosure requirements for such inventions. Prashant Reddy T is one of our most prolific bloggers (his posts can be accessed here). He is also the co-author of two books- “Create, Copy, Disrupt: India’s Intellectual Property Dilemmas” (OUP, 2017)

Delhi High Court Stirs the Pot for Biotech Patent Applicants in India  Read More »

Optimus’ Linezolid Patent Revoked After Post-Grant Opposition

The Indian Patent Office has revoked the Patent No. 281489 (Application No. 201641013830) subsequent to a post-grant opposition by Symed Labs. The patent was revoked for lacking obviousness/inventive step, not being a patentable invention under section 3(d) and failure to disclose requisite information under section 8 of the Patents Act. The patent was granted on 20 March, 2017 and the post grant opposition was filed on 5 March, 2018. The patent relates to Linezolid, an antibiotic primarily used against pneumonia, skin

Optimus’ Linezolid Patent Revoked After Post-Grant Opposition Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (February 17 – February 23)

(Thanks to Aditi and Khushi for the case summaries) Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! A quick glance at last week – Madras HC accepts a US District Court’s Letter Rogatory to furnish confidential information, a look at Functional Fallacies in Thomson Reuters vs Ross Intelligence and many more. We also have the initiation of our attempt to bring IP conversations to wider audiences through multilingual writing! This and much more in this

SpicyIP Weekly Review (February 17 – February 23) Read More »

Pfizer v. Softgel: The Errors of Comity

On January 28, the Madras High Court passed an order related to an ongoing patent dispute in the United States. The dispute concerned Cipla’s and Zenara (Hikma)’s ANDA applications seeking approval to market their generic versions of Vyndamax (tafamidis), a drug used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), in the US. Pfizer, the petitioner, argued before the US District Court, Delaware that the ANDA applications infringed its US patent. To further prove its allegation Pfizer requested the Court to issue

Pfizer v. Softgel: The Errors of Comity Read More »

Tier I, Tier II, Time for Experts; The Curious Case of Scientific Advisers, Party Expert and Two Tiered Confidentiality Club 

Image generated by DALL E and edited by Canva. On January 8, 2025, the Delhi High Court, presided over by Hon’ble Justice Amit Bansal, delivered a significant ruling in the case of Syngenta Limited and Anr. vs. GSP Crop Science Private Limited (See here). This case pertains to patent infringement concerning two process patents related to the fungicide Azoxystrobin. The Court allowed the Party Expert to be privy to the documents accessed by the Scientific Advisers appointed by the Bench.

Tier I, Tier II, Time for Experts; The Curious Case of Scientific Advisers, Party Expert and Two Tiered Confidentiality Club  Read More »

Call for Suggestions on the Draft Guidelines for Processing Patent Applications of AYUSH Systems and Related Inventions (February 28)

The office of CGPDTM has invited comments on the Draft Guidelines for Processing Patent Applications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patent applications of Ayush systems and related inventions. The guidelines are available on the IPIndia website here. The deadline for sharing suggestions with the CGPDTM is February 28. Interested readers can share their suggestions on anita[dot]ipo[at]nic[dot]in.

Call for Suggestions on the Draft Guidelines for Processing Patent Applications of AYUSH Systems and Related Inventions (February 28) Read More »

Comments Invited on “AI Governance and Guidelines Development” Report (February 27)

The Ministry of Electronics and IT (MeitY) has published a report titled ‘AI Governance and Guidelines Development’. The Report was prepared by a Subcommittee, under the guidance of an Advisory Group (chaired by the Principal Scientific Advisor) to provide recommendations on AI governance in India. IndiaAI, an initiative of the MeitY has invited comments on the report. The comments are invited by February 27, 2025. Interested readers can share their comments by filling the form here

Comments Invited on “AI Governance and Guidelines Development” Report (February 27) Read More »

After ANI, Bollywood Music Labels Have a Face-off with OpenAI

On the news of the Indian Music Industry and music labels seeking to be impleaded as parties in the ongoing ANI v. OpenAI case, Anjali Tripathi writes on the issues raised by the trade body and labels and the overall impact this case can have on the music industry. Anjali Tripathi is a fourth-year law student at JGLS with an interest in IP rights, access to education, and the creative arts. After ANI, Bollywood Music Labels Have a Face-off with

After ANI, Bollywood Music Labels Have a Face-off with OpenAI Read More »

Scroll to Top